Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Open Access
- 8 March 2025
- journal article
- review article
- Published by Springer Nature in Current Oncology Reports
- Vol. 27 (4) , 415-430
Abstract
Purpose of Review: Cutaneous T-Cell Lymphoma (CTCL) poses challenges both in diagnosis and prognosis. The purpose of this review is to address the role of profiling immune and non-immune cells in the tumor microenvironment (TME) as it provides information for better diagnosis, prognosis, biomarker discovery, and personalized treatment strategies. Recent Findings: Recent evidence suggests that the progression of CTCL is closely linked to the Tumor Microenvironment (TME) which comprises various cell types including immune cells, stromal cells, blood vessels, and the extracellular matrix. Cell profiling within the TME demonstrates the perplexity of intracellular communication of the different cell fates and their mediators as the disease progresses. Summary: CTCL as a rare form of non-Hodgkin lymphoma often misdiagnosed due to its similarity to other skin conditions. It encompasses diseases like Mycosis fungoides (MF) and Sézary Syndrome (SS), with the latter being more severe. Advances in studying the TME have shown its pivotal role in CTCL progression, highlighting the need for comprehensive cell profiling to enhance diagnosis, prognosis, and treatment personalization.Keywords
This publication has 125 references indexed in Scilit:
- CCR4‐IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T‐cell lymphoma in a mouse CTCL modelFEBS Open Bio, 2023
- CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driverEuropean Journal of Immunology, 2021
- Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndromeCancer Immunology, Immunotherapy, 2017
- The immunological function of CD52 and its targeting in organ transplantationInflammation Research, 2017
- Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusionMolecular Genetics & Genomic Medicine, 2014
- Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell LymphomaArchives of Dermatology, 2010
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse modelCancer Immunology, Immunotherapy, 2008
- Prognostic Value of Blood Eosinophilia in Primary Cutaneous T-Cell LymphomasArchives of Dermatology, 2004
- Increased angiogenesis in cutaneous T-cell lymphomasPathology and Oncology Research, 2004
- ImmunotoxinsBiotherapy, 1991